PHARMANIAGA BERHAD
Last Price: 0.365
TTM Dividend Yield : 0%
Coming Quarter Report: ~ 2025-02-29
Yahoo Google Bursa Web TradingView
Sector: Pharmaceuticals
Pharmaniaga Berhad is an investment holding company. The Company’s principal activities include manufacturing of generic pharmaceuticals, logistics and distribution, sales and marketing, supply of medical products and services, including hospital equipment, and trading and wholesaling of consumer products. The Company operates through two segments: Logistics and distribution, and Manufacturing. The Logistics and distribution segment is engaged in the distribution, trading and wholesaling of pharmaceutical and medical products, as well as supply and installation of medical and hospital equipment in Malaysia and Indonesia. It also includes supply chain management, order management and warehousing. The Manufacturing segment is engaged in manufacturing of pharmaceutical products. The product portfolio includes oral solid dosages, liquid, cream and small volume injectables. It manufactures general pharmaceutical, including penicillin, cephalosporin and over-the-counter (OTC) products.
**Do feedback to us if you see any error on the data
**Data before 2015 may not be accurate
**Dividend Yield calculated base on the last price of the year
PHARMA Dividend Yield Trend
PHARMA Quarter DY Yield
Year | Financial Year | DY_Type | Announced | EX Date | Payment Date | DY($) | Yield% |
---|---|---|---|---|---|---|---|
2022 | 31/12/2022 | Third Interim | 30/11/2022 | 08/12/2022 | 06/01/2023 | 0.006 | 1.10 |
2022 | 31/12/2022 | Second Interim | 19/08/2022 | 09/09/2022 | 04/10/2022 | 0.005 | 0.92 |
2022 | 31/12/2022 | First Interim | 20/05/2022 | 07/06/2022 | 06/07/2022 | 0.008 | 1.47 |
2021 | 31/12/2021 | Fourth Interim | 17/02/2022 | 07/03/2022 | 05/04/2022 | 0.05 | 9.17 |
2021 | 31/12/2021 | Third Interim | 19/11/2021 | 06/12/2021 | 29/12/2021 | 0.02 | 3.67 |
2021 | 31/12/2021 | Second Interim | 20/08/2021 | 07/09/2021 | 30/09/2021 | 0.015 | 2.75 |
2021 | 31/12/2021 | Interim | 21/05/2021 | 04/06/2021 | 06/07/2021 | 0.04 | 7.34 |
2020 | 31/12/2020 | Interim | 17/03/2021 | 30/03/2021 | 22/04/2021 | 0.01 | 1.83 |
2020 | 31/12/2020 | Interim | 19/11/2020 | 04/12/2020 | 29/12/2020 | 0.015 | 2.75 |
2020 | 31/12/2020 | Interim | 19/08/2020 | 07/09/2020 | 06/10/2020 | 0.025 | 4.59 |
2020 | 31/12/2020 | Interim | 19/05/2020 | 04/06/2020 | 30/06/2020 | 0.06 | 11.01 |
2019 | 31/12/2019 | Second Interim | 23/08/2019 | 11/09/2019 | 11/10/2019 | 0.025 | 4.59 |
2019 | 31/12/2019 | First Interim | 16/05/2019 | 03/06/2019 | 27/06/2019 | 0.06 | 11.01 |
2018 | 31/12/2018 | Interim | 21/02/2019 | 08/03/2019 | 10/04/2019 | 0.02 | 3.67 |
2018 | 31/12/2018 | Interim | 19/11/2018 | 03/12/2018 | 03/01/2019 | 0.05 | 9.17 |
2018 | 31/12/2018 | Second Interim | 17/08/2018 | 03/09/2018 | 18/09/2018 | 0.04 | 7.34 |
2018 | 31/12/2018 | First Interim | 16/05/2018 | 30/05/2018 | 20/06/2018 | 0.05 | 9.17 |
2017 | 31/12/2017 | Interim | 27/02/2018 | 13/03/2018 | 28/03/2018 | 0.06 | 11.01 |
2017 | 31/12/2017 | Interim | 15/11/2017 | 29/11/2017 | 15/12/2017 | 0.05 | 9.17 |
2017 | 31/12/2017 | Interim | 16/08/2017 | 29/08/2017 | 15/09/2017 | 0.04 | 7.34 |
2017 | 31/12/2017 | Interim | 16/05/2017 | 29/05/2017 | 07/06/2017 | 0.04 | 7.34 |
2016 | 31/12/2016 | Interim | 21/02/2017 | 07/03/2017 | 17/03/2017 | 0.03 | 5.50 |
2016 | 31/12/2016 | Interim | 21/11/2016 | 05/12/2016 | 15/12/2016 | 0.04 | 7.34 |
2016 | 31/12/2016 | Interim | 19/08/2016 | 02/09/2016 | 20/09/2016 | 0.05 | 9.17 |
2016 | 31/12/2016 | Interim | 13/05/2016 | 01/06/2016 | 28/06/2016 | 0.04 | 7.34 |
2015 | 31/12/2015 | Interim | 15/02/2016 | 01/03/2016 | 25/03/2016 | 0.07 | 12.84 |
2015 | 31/12/2015 | Interim | 26/11/2015 | 09/12/2015 | 21/12/2015 | 0.09 | 16.51 |
2015 | 31/12/2015 | Interim | 17/08/2015 | 01/09/2015 | 15/09/2015 | 0.07 | 12.84 |
2015 | 31/12/2015 | Interim | 18/05/2015 | 01/06/2015 | 25/06/2015 | 0.07 | 12.84 |
2014 | 31/12/2014 | Interim | 23/02/2015 | 09/03/2015 | 26/03/2015 | 0.12 | 22.02 |
2014 | 31/12/2014 | Interim | 21/11/2014 | 05/12/2014 | 30/12/2014 | 0.08 | 14.68 |
2014 | 31/12/2014 | Interim | 21/08/2014 | 05/09/2014 | 24/09/2014 | 0.04 | 7.34 |
2014 | 31/12/2014 | Interim | 14/05/2014 | 29/05/2014 | 16/06/2014 | 0.04 | 7.34 |
2013 | 31/12/2013 | Interim | 24/02/2014 | 10/03/2014 | 02/04/2014 | 0.062 | 11.38 |
2013 | 31/12/2013 | Interim | 19/11/2013 | 03/12/2013 | 24/12/2013 | 0.03 | 5.50 |
2013 | 31/12/2013 | Second Interim | 16/08/2013 | 30/08/2013 | 24/09/2013 | 0.0341 | 6.26 |
2013 | 31/12/2013 | First Interim | 15/05/2013 | 30/05/2013 | 28/06/2013 | 0.075 | 13.76 |
2012 | 31/12/2012 | Interim | 18/02/2013 | 04/03/2013 | 27/03/2013 | 0.1 | 18.35 |
2012 | 31/12/2012 | Interim | 06/11/2012 | 21/11/2012 | 17/12/2012 | 0.1 | 18.35 |
2012 | 31/12/2012 | Second Interim | 08/08/2012 | 23/08/2012 | 12/09/2012 | 0.075 | 13.76 |
2012 | 31/12/2012 | First Interim | 03/05/2012 | 16/05/2012 | 18/06/2012 | 0.075 | 13.76 |
2011 | 31/12/2011 | Second Interim | 21/02/2012 | 08/03/2012 | 28/03/2012 | 0.21 | 38.53 |
2011 | 31/12/2011 | First Interim | 21/12/2011 | 06/01/2012 | 26/01/2012 | 0.09 | 16.51 |
2010 | 31/12/2010 | Interim | 20/07/2010 | 02/08/2010 | 19/08/2010 | 0.1 | 18.35 |
2009 | 31/12/2009 | Interim | 05/05/2010 | 10/06/2010 | 15/07/2010 | 0.37 | 67.89 |
2002 | 31/12/2002 | Interim | 22/11/2002 | 13/12/2002 | 26/12/2002 | 0.025 | 4.59 |
PHARMA Annual DY Yield
Year | Annual DY($) | Frequency per yr | SpecialDY | Yield% |
---|---|---|---|---|
2022 | 0.019 | 3 | No | 3.49 |
2021 | 0.125 | 4 | No | 22.94 |
2020 | 0.11 | 4 | No | 20.18 |
2019 | 0.085 | 2 | No | 15.60 |
2018 | 0.16 | 4 | No | 29.36 |
2017 | 0.19 | 4 | No | 34.86 |
2016 | 0.16 | 4 | No | 29.36 |
2015 | 0.3 | 4 | No | 55.05 |
2014 | 0.28 | 4 | No | 51.38 |
2013 | 0.2011 | 4 | No | 36.90 |
2012 | 0.35 | 4 | No | 64.22 |
2011 | 0.3 | 2 | No | 55.05 |
2010 | 0.1 | 1 | No | 18.35 |
2009 | 0.37 | 1 | No | 67.89 |
2002 | 0.025 | 1 | No | 4.59 |
PHARMA Quarter Report History
Q Date | Announced | Revenue | P/L | EPS | Margin | QoQ% | YoY% |
---|---|---|---|---|---|---|---|
30/09/2024 | 26/11/2024 | 1,000,000,000 | 101,000,000.00 | 7.01 | 10.10 | 3,507.14 | 304.87 |
30/06/2024 | 21/08/2024 | 838,300,000 | 2,800,000.00 | 0.19 | 0.33 | -89.06 | 40.00 |
31/03/2024 | 27/05/2024 | 965,000,000 | 25,600,000.00 | 1.78 | 2.65 | 178.29 | 884.62 |
31/12/2023 | 29/02/2024 | 789,800,000 | -32,700,000.00 | -2.39 | -4.14 | 33.67 | 94.93 |
30/09/2023 | 29/11/2023 | 885,500,000 | -49,300,000.00 | -3.67 | -5.57 | -2,565.00 | -673.26 |
30/06/2023 | 11/08/2023 | 848,700,000 | 2,000,000.00 | 0.15 | 0.24 | -23.08 | 177.01 |
31/03/2023 | 18/05/2023 | 880,500,000 | 2,600,000.00 | 0.20 | 0.30 | 100.40 | -90.61 |
31/12/2022 | 27/02/2023 | 862,700,000 | -644,400,000.00 | -49.19 | -74.70 | -7,593.02 | -853.68 |
30/09/2022 | 24/11/2022 | 924,700,000 | 8,600,000.00 | 0.66 | 0.93 | 1,091.14 | -82.73 |
30/06/2022 | 19/08/2022 | 761,100,000 | 722,000.00 | 0.06 | 0.09 | -97.39 | -94.73 |
PHARMA Quarter Profit Trend
PHARMA Annual Profit Trend
Cash Flow
In financial accounting, operating cash flow (OCF), cash flow provided by operations, cash flow from operating activities (CFO) or free cash flow from operations (FCFO), refers to the amount of cash a company generates from the revenues it brings in, excluding costs associated with long – term investment  on capital items or investment in securities.(From Wiki)
PHARMA Annual Cash Flow
Â
ROE & Payout Ratio
Return on equity (ROE) is a measure of financial performance calculated by dividing net income by shareholders’ equity. Because shareholders’ equity is equal to a company’s assets minus its debt, ROE is considered the return on net assets. ROE is considered a measure of the profitability of a corporation in relation to stockholders’ equity. (From Investopedia)
The payout ratio is a financial metric showing the proportion of earnings a company pays its shareholders in the form of dividends, expressed as a percentage of the company’s total earnings. On some occasions, the payout ratio refers to the dividends paid out as a percentage of a company’s cash flow. The payout ratio is also known as the dividend payout ratio. (From Investopedia)
Pharmaniaga Bhd is engaged in the manufacture of generic pharmaceuticals and medical devices, sales and marketing as well as the distribution of medical products and hospital equipment. The company is also involved in logistics and distribution. The group operates in three segments – Logistics and distribution, Manufacturing, and Indonesia. Maximum revenue is generated by the Logistics and distribution segment.